Dr. Eugene Wade, MD
What this data tells you about Dr. Wade
Dr. Eugene Wade is a family medicine specialist in Kernersville, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wade performed 275,000 Medicare services across 1,933 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wade received a total of $378 from 9 pharmaceutical and/or device companies across 11 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wade is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Efgartigimod alfa-fcab injection, 2 mg An injection of efgartigimod alfa-fcab administered at a dose of 2 mg. |
60,400 | $24 | $91 |
| Tezepelumab injection, 1 mg An injection of tezepelumab-ekko, a medication administered in 1 mg doses. |
24,780 | $15 | $52 |
| Romosozumab injection (Evenity) for osteoporosis | 24,150 | $8 | $33 |
| Inclisiran injection (Leqvio) for cholesterol | 23,856 | $9 | $70 |
| Injection, eptinezumab-jjmr, 1 mg | 20,600 | $13 | $51 |
| Injection, tildrakizumab, 1 mg | 17,500 | $111 | $492 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
16,500 | $1 | $11 |
| Denosumab injection (Prolia/Xgeva) | 12,421 | $19 | $98 |
| Injection, mepolizumab, 1 mg | 11,800 | $23 | $80 |
| Privigen immune globulin injection, 500 mg An intravenous injection of Privigen, a non-lyophilized immune globulin product, administered in a 500 mg dose. |
10,760 | $37 | $204 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
10,710 | $0 | $14 |
| Omalizumab injection (Xolair) for asthma/allergy | 10,095 | $31 | $103 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
7,550 | $34 | $132 |
| Ocrelizumab infusion (Ocrevus) for MS | 6,600 | $44 | $149 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
5,220 | $26 | $280 |
| Injection, benralizumab, 1 mg | 3,570 | $133 | $551 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
3,450 | $63 | $225 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,119 | $10 | $53 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
933 | $46 | $294 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
874 | $0 | $6 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
758 | $15 | $60 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
362 | $91 | $341 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
294 | $20 | $80 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
201 | $11 | $50 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
129 | $4 | $46 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
120 | $1 | $8 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
115 | $6 | $159 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
90 | $1 | $10 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
43 | $3 | $36 |
Industry Payment Transparency
Open Payments through 2023 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2023)
All-time payments by company (2019-2023) ›
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
14.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wade is a mixed practice specialist, with above-average Medicare volume (top 0% in NC), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wade experienced with efgartigimod alfa-fcab injection, 2 mg?
Does Dr. Wade receive payments from pharmaceutical companies?
How do Dr. Wade's costs compare to other family medicine physicians in Kernersville?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology